RALEIGH, N.C. and COLUMBUS, Ohio, Sept. 18, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH) and Deep Lens, Inc., announced today a new strategic relationship to accelerate patient ...

RALEIGH, N.C., April 21, 2021 (GLOBE NEWSWIRE) -- PRA Health Sciences (NASDAQ: PRAH) announced today the expansion of its pharmacovigilance solution to offer full post-marketing services for ...

Through this strategic partnership, the network aims to reach more than 25,000 physicians and 40 million patients, accelerating trial recruitment and enrollment efforts and expanding patients’ access ...

Robert W. Baird analyst Eric Coldwell maintained a Hold rating on PRA Health Sciences (NASDAQ:PRAH) on Wednesday, setting a price... Robert W. Baird analyst Eric Coldwell maintained a Buy rating on ...

PRA Health Sciences (PRAH) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2019. This widely-known consensus outlook ...

* Pra health sciences inc - ‍updating its full year 2017 service revenue guidance to between $1.825 billion and $1.855 billion * Pra health sciences inc - sees ‍fy gaap net income per diluted share to ...

ICON Public is a global clinical research organization that provides services for the pharmaceutical, biotechnology, and medical device industries. The clinical research organization sector is ...

The Japanese pharmaceutical company Takeda Pharmaceutical and the Raleigh, N.C.-based contract research organization PRA Health Sciences have entered a new partnership. Here's what you need to know: 1 ...

PRA Health Sciences, a contract research organization serving pharmaceutical clients, and its board of directors were hit with a shareholder lawsuit Thursday in California Southern District Court. The ...

PRA Health Sciences (PRAH) is one of the world's leading global contract research organizations (CROs) by revenue, providing outsourced clinical development services to the biotechnology and ...